Pricing
The creation of negotiation strategies allows an efficient definition of the price and reimbursement of health technologies, also through the use of new frameworks for the most innovative technologies (ATMPS, digital therapeutics, agnostic drugs, drug-device combination, ...) with the construction of specific payment models that support innovative contracts (risk sharing, MEA, …).